CRS is driven by the release of inflammatory cytokines, including IL-2, IL-6, IL-10, IFNγ, and TNFα [26,27], as a direct consequence of the response to CAR-T cells and additional surrounding immune cells, leading to an overall hyperinflammatory response [26,27,28]. This evidence concerns the gene IL6 and congenital rubella syndrome.